Observational Study of the Safety of Intravenous Artesunate Treatment of Pregnant Women and Their Infants

Recruiting now

Conditions studied: Pregnancy, Malaria

In brief

This study is a prospective observational study in which a female patient who received IV Artesunate while pregnant can volunteer to provide information about her pregnancy and the outcome of her pregnancy. Information will be collected from patient's provider, the patient's obstetrician, the child's pediatrician, or other relevant healthcare provider.

Key facts

Study ID

NCT05285735

Run by

Amivas Inc.

People needed

25

Starts

2022-06-08

Expected to finish

2029-07-01

Last updated by the study team

2024-01-30

Who can join

Age: 15 and older, up to 100. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

• Patient received IV Artesunate
• Patient was pregnant while receiving IV Artesunate
• Patient was at least 15 years of age
• Patient or legal guardian/representative gave consent for the study and to collect data from her physicians

You may not qualify if…

• None

Where it is running

• 4C Pharma Solutions — Piscataway, New Jersey, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.